Active surveillance an option for some low-risk prostate cancer patients
Active surveillance of individuals with very-low-risk prostate cancer who are also on 5 α-reductase inhibitor therapy for benign prostatic hyperplasia seems to be a viable therapeutic option, say researchers.
Source: MedWire News - Urology - Category: Urology & Nephrology Source Type: news
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology